Searchable abstracts of presentations at key conferences in endocrinology

ea0012oc24 | Pituitary, ovary and steroids | SFE2006

Influence of C-type natriuretic peptide (CNP) on cell proliferation in αT3-1 gonadotrophs and GH3 somatotrophs

Thompson IR , Jonas KC , Wolf S , Lawson C , Wheeler-Jones CP , Fowkes RC

C-type natriuretic peptide (CNP) acts via its specific membrane-bound guanylyl cyclase receptor, GC-B, to stimulate cGMP production. Stimulation of cGMP impinges upon PKG and PKA signalling, leading to cell proliferation and cell cycle events. In endothelial cells, CNP is thought to perform a predominantly anti-mitogenic role, but the role of CNP on cell proliferation, cell cycle and DNA synthesis in pituitary cell lines has yet to be established. Using the mouse gonadotroph-d...

ea0029p298 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

The combined use of serum interleukin 6 and C-reactive protein is better than either alone in predicting cardiovascular events in a Chinese population

Lam K. , Chow W. , Yeung C. , Tso A. , Yuen M. , Fong C. , Wat N. , Lam T. , Lo S. , Tse H. , Cheung B.

Objectives: Obesity is associated with an increase in cardiovascular risk. We investigated whether the measurement of obesity-related biomarkers could enhance the prediction of cardiovascular (CVD) events when used in conjunction with traditional risk factors.Methods: We studied subjects in the Hong Kong Cardiovascular Risk Factors Prevalence Study 2 (CRISPS 2) cohort without previous cardiovascular disease. Baseline serum levels of several biomarkers kn...

ea0029p639 | Diabetes | ICEECE2012

Serum high sensitivity c-reactive protein as predictor of metabolic syndrome and its relationship with albuminuria in type 2 diabetes mellitus

del Canizo-Gomez F , Moreno-Ruiz I , Silveira-Rodriguez B , De Gorospe C , Gonzalez-Losada T , Segura-Galindo A

The high sensitivity C-reactive protein (hs-CRP), mediator of atherosclerotic disease, is known to be a sensitive predictor of coronary heart disease in type 2 diabetes mellitus (T2DM).Aims: To evaluate the relationship of hs-CRP levels to metabolic syndrome (MS) and albuminuria in T2DM.Methods: Four hundred and eighty-eight T2DM subjects were recruited. Patients with hs-CRP ≥10 mg/l, creatinine ≥1.4 mg/dl, chronic infl...

ea0020s20.1 | Thyroid cancer | ECE2009

C Cell neoplasia

Elisei Rossella

Parafollicular C-Cells represent 1% of thyroid cells and differ from follicular cells for their origin from the neural crest. At variance with follicular cells, their growth and function are independent from thyrotropin stimulating hormone (TSH), they do not take up iodine and they produce and secrete calcitonin (CT) but not thyroglobulin. C-Cell Hyperplasia (CCH) is defined as an increased number of normal C-cells (i.e. 50 or more C-cells in at least one low-power field (100&...

ea0073pep9.8 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

Romero LLuch Ana R. , Disotuar Suset Dueñas , Tous Romero Marai C. , Fernández Peña J. Ignacio , Cuenca Cuenca J. Ignacio , Elena Navarro

IntroductionBased on the evidence available back then, in 2015 we developed a provincial multicenter protocol for screening and follow up of no-index patients with SDHB and SDHC mutations.Objectives1. To evaluate the performance of the protocol designed for the follow-up of asymptomatic SDHB and C carriers. 2. To describe the penetrance of manifestations associated with hereditary PGL-FEO syndromes type 3 and...

ea0009p92 | Endocrine tumours and neoplasia | BES2005

Is survivin regulated by c-Myc?

Cosgrave N , Hill A , Young L

Introduction: In endocrine tumours, such as that of the breast, the protein survivin has emerged as a unique regulator of cell death. We have previously shown that bFGF regulates survivin expression through the MAP kinase cascade. The transcriptional complex myc/max is an oncogene that lies downstream of the MAP kinase pathway suggesting a possible role in survivin's regulation.Aim: To determine if bFGF can mediate survivin expression by signalling throu...

ea0022p780 | Thyroid | ECE2010

The serum C-reactive proteine in dysthyreosis

Laszlo Annamaria , Pascanu Ionela , Kolcsar Melinda , Gliga Camelia , Schiopu Alexandru

Introduction: The thyroid is a multifaced endocrine gland. By its hormones it has an effect on almost all organs of the body, metabolism and defence system too. The relationship between the thyroid hormones and the nonspecific defence system has been less studied.Aim: To study and prove whether the endogenous thyroxin (FT4) is involved in the nonspecific defence system of the organism. We followed the correlation between the FT4 and...

ea0016p813 | Thyroid | ECE2008

Changes in cystatin C during the treatment of subclinical hypothyroidism

Velija-Asimi Zelija , Heljic Becir

Background: Serum cystatin C is a novel marker for kidney function that has been claimed to be superior to serum creatinine. Cystatin C concentrations increased in the hyperthyroid patients and decreased in the hypothyroid patients. The cystatin C test detects kidney disease at earlier stages, before symptoms appear and creatinine levels rise. Another advantage is that, unlike creatinine, blood levels of cystatin C are less influenced by age, gender, race, or lean muscle mass,...

ea0022p521 | Male reproduction | ECE2010

Effect of melatonin in the phosphorylation of ERK42/44, P38 and JNK46/54, and the expression of c-jun and c-fos in hamster Leydig cells

Rossi Soledad , Matzkin Maria , Calandra Ricardo , Frungieri Monica

Previously, we have described an inhibitory role of melatonin (Mel) in the expression of StAR and key steroidogenic enzymes, as well as in the regulation of testosterone production in testes of Syrian hamsters. The goal of the present work was to further investigate the signaling pathway involves in the testicular action of Mel. Thus, Leydig cells were purified from reproductively active hamsters killed by asphyxia with carbon dioxide, and incubated in the presence of Mel and ...

ea0086p214 | Metabolism, Obesity and Diabetes | SFEBES2022

C-peptide assessments- are we doing it correctly?

Oo Win , George Bethany , Partridge Helen , Hart Tanya , Page Georgina , Holt Helen , Brooks Augustin , Richardson Tristan

Background: C-peptide is an amino-acid chain which is an equimolar marker of endogenous insulin. It is used to investigate the cause of non-diabetic hypoglycaemia and classification of diabetes. C-peptide can only be interpreted with a paired venous glucose <3 mmol/l for non-diabetic hypoglycaemia, and >4 mmol/l for diabetes classification.Aims and Objectives: To determine if: 1. C-peptide tests were requested for appropriate indication 2. Tests ...